Shares in Reva Medical (ASX:RVA) rose today after the medical device maker posted its third-quarter financial results.
The San Diego, Calif.-based company recorded a net loss of -$9 million on sales of $93,000 for the 3 months ended Sept. 30, for sales growth of 447% compared with the same period last year. Earnings per share were -22¢.
Get the full story at our sister site, Drug Delivery Business News.
The post Sales for Reva Medical up in Q3 following launch of bioresorbable scaffold appeared first on MassDevice.